2023 annual financial data

Neuphoria Therapeutics 2023 Financial results

Neuphoria Therapeutics 2023 financial results with verified reported values.

Direct answer

Revenue was 0 USD.

Operating income was -33,086,723 USD and net income was -32,181,704 USD.
Operating cash flow was -9,846,030 USD.
Alpha Vantage

Get free Neuphoria Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-33,086,723 USD
Net income
-32,181,704 USD
Operating cash flow
-9,846,030 USD

Explore related company data

View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Neuphoria Therapeutics financial years